NEW YORK, May 17 (GenomeWeb) - BioNanomatrix today said that it has been awarded a grant from the National Cancer Institute as well as new seed financing from two venture investors, 21 Ventures and Ben Franklin Technology Partners of Southeastern Pennsylvania.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
